Page last updated: 2024-10-26

e 4031 and Leukemia

e 4031 has been researched along with Leukemia in 1 studies

E 4031: class III anti-arrhythmia agent; structure given in UD

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, F1
Li, H1
Du, W1
Huang, S1

Other Studies

1 other study available for e 4031 and Leukemia

ArticleYear
Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation.
    Hematology (Amsterdam, Netherlands), 2011, Volume: 16, Issue:3

    Topics: Apoptosis; beta Catenin; Cell Cycle; Cell Proliferation; Chemokine CXCL12; Cyclin D1; Dose-Response

2011